Pin Ren

Baseline type 2 biomarker levels and response to tezepelumab in severe asthma

Jonathan Corren, Tuyet‐Hang Pham, Esther García Gil et al. · Allergy · 2021 · 120 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial

Jean Chastre, Bruno François, Marc Bourgeois et al. · Critical Care · 2022 · 93 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial

Bruno François, Hasan S. Jafri, Jean Chastre et al. · The Lancet Infectious Diseases · 2021 · 87 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +11

Dysplastic Nodules with Glypican-3 Positive Immunostaining: A Risk for Early Hepatocellular Carcinoma

Li Gong, Longxiao Wei, Pin Ren et al. · PLoS ONE · 2014 · 22 citations · Full text

Medicine, Oncology, Pathology +17

Tezepelumab Reduces Multiple Key Inflammatory Biomarkers in Patients with Severe, Uncontrolled Asthma in the Phase 2b PATHWAY Study

Tuyet‐Hang Pham, Pin Ren, J R Parnes et al. · 2019 · 21 citations

Veterinary Medicine, Immunology, Pharmacology +14